SRM Proteomics
SRM proteomics (Selected Reaction Monitoring, SRM) is a highly sensitive mass spectrometry-based quantitative technique designed for the precise detection and quantification of target proteins in complex biological samples. By specifically monitoring selected peptide ions, SRM enables the high-specificity identification and quantification of proteins in complex biological matrices. The fundamental principle of SRM proteomics is the detection of precursor and fragment ions of specific peptides using a mass spectrometer, based on their mass-to-charge ratio (m/z). Initially, researchers select peptides uniquely representative of the target protein and determine their precursor ion signatures via mass spectrometry. These peptides are then fragmented, generating product ions that are monitored to assess their relative abundance. By analyzing these ion intensities, researchers can accurately quantify the variations in target protein levels across different samples. A key advantage of SRM proteomics is its exceptional selectivity and sensitivity, allowing the reliable detection of low-abundance proteins while minimizing interference from background noise and other co-eluting species commonly encountered in mass spectrometry. SRM proteomics has broad applications, particularly in clinical diagnostics, disease research, and pharmaceutical development. In medical diagnostics, SRM facilitates the identification of novel biomarkers for early disease detection and prognosis evaluation. For instance, in oncology, SRM proteomics enables the monitoring of tumor biomarkers, aiding in the identification of key proteins involved in cancer progression. Additionally, SRM is valuable for evaluating drug-induced alterations in protein expression, thereby informing assessments of therapeutic efficacy and safety. In drug development, SRM proteomics provides crucial data to support targeted therapies, contributing to the design of more precise therapeutic interventions.
Despite its numerous advantages, SRM proteomics presents certain challenges. A critical factor in successful SRM quantification is the careful selection of target peptides. Protein digestion can yield multiple peptide fragments, and selecting the most specific peptides while avoiding interference from co-eluting ions remains a technical challenge. Furthermore, the effectiveness of SRM is constrained by instrument sensitivity, particularly when detecting low-abundance proteins, where both mass spectrometer resolution and sensitivity are crucial. Consequently, optimizing experimental parameters and mass spectrometry conditions is essential to ensure reliable and reproducible results.
MtoZ Biolabs possesses extensive expertise in proteomics and offers precise, high-sensitivity SRM-based quantitative analysis services. Our mass spectrometry platform supports high-throughput, targeted protein quantification, catering to diverse research needs. Whether for disease research, pharmaceutical development, or clinical applications, we provide state-of-the-art technical support. By partnering with MtoZ Biolabs, researchers gain access to comprehensive analytical services, facilitating advancements in proteomics research and biomedical discovery.
MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider.
Related Services
How to order?
